One crucial factor that plays a pivotal role in the success of organ-on-cip models is immunocompetence. In this blog post, we delve into the significance of immunocompetence in organ-on-chip models and how it opens new avenues for advancing medical research.
Learn the skills to integrate organ-on-chip technology into your lab work with the Dynamic42 Academy. If this resonates with you, this blog will help you to understand if our organ-on-chip class is for you. We will give you a deep dive into the reasons to attend our course, what we teach in the course, and what past participants have to say.
A comprehensive summary of available organ-on-chip courses, detailing the provider, content and location. Organ-on-chip technology is an amazing technique to model human, physiological mechanisms on a small scale without the use of animal models. If you as a researcher are versed in cell culture, learning how to create your own organ models is absolutely feasible in just a few months.
We look back on 2023 - from significant milestones, groundbreaking developments and trusting partnerships to new faces in our team. We'll take you with us as we review the past year.
In this article, we will discuss common issues observed when working with biochips made of PDMS, most commonly used alternatives, and desired properties for biochip materials. But most importantly, we will present alternative biochips showing low adsorptions rates but also unique biocompatibility for high grade drug screening.
In this blog we will provide you with an introduction to the drug development process from target validation to post-market surveillance to give you a better understanding on how new drugs are being developed.
As an expert in business development, Georg enriches our team at Dynamic42. With his creative approach and many years of experience in medical technology and project management, Georg is a valuable addition to our team.
Organ-on-Chip technology (OoC) has the potential to shape the future of drug research. It allows the simulation of human organs on a chip, enabling more reliable tests for drug development.
Summary of our work that established a human liver microphysiological model as an in vitro platform for the evaluation of drug-induced liver injury, published in Nature Scientific Reports. This case study sheds light on the effects of the known hepatotoxic antibiotic trovafloxacin and the commonly used analog levofloxacin on human liver tissue, using an innovative chip-based liver model.
Lately Thomas Sommermann joined Dynamic42. Thomas is an experienced scientist in the field of immunology and shares our vision regarding the enormous potential of the organ-on-chip technology.